Today, Hua Medicine announced that the company has obtained the "Drug Production License" for the world's first innovative drug under research, dorzagliatin, issued by Shanghai MPA.
Today, Hua Medicine announced that it has obtained the "Pharmaceutical Production License" issued by Shanghai MPA to develop the world's first innovative drug, Dorzagliatin.
Hua medicine announced today that the company has obtained the drug production license of dorzagliatin, the world's first new drug under development, issued by Shanghai MPa.<br>